These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1392162)

  • 1. [Multiple myeloma: current therapeutic approaches].
    Troussard X; Bauduer F; Leporrier M
    Bull Cancer; 1992; 79(3):231-42. PubMed ID: 1392162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current and future approaches to therapy for multiple myeloma].
    Nara N
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of multiple myeloma: current aspects].
    Betticher DC; Cerny T; Fey MF
    Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of multiple myeloma].
    Ludwig H; Kührer I
    Wien Klin Wochenschr; 1994; 106(14):448-54. PubMed ID: 7941591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
    Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
    Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of refractory multiple myeloma. II. Therapy using high doses of alkylating cytostatic agents and radiotherapy in addition to interferon and bone marrow transplantation].
    Adam Z
    Vnitr Lek; 1993 Apr; 39(4):385-400. PubMed ID: 8351869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent biological and therapeutic advances in multiple myeloma].
    Coppetelli U; Avvisati G; Tribalto M; Cantonetti M; La Verde G; Petrucci T; Stasi R; Papa G
    Recenti Prog Med; 1992 Sep; 83(9):520-7. PubMed ID: 1439122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of multiple myeloma].
    La Verde G; Pulsoni A; Petrucci MT; Mandelli F
    Recenti Prog Med; 1997 Apr; 88(4):186-93. PubMed ID: 9206817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of multiple myeloma.
    Richards JD; Singer CR; Tobias JS
    Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon therapy in multiple myeloma].
    Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of multiple myeloma.
    Barlogie B; Jagannath S; Tricot G; Desikan KR; Fassas A; Siegel D
    Adv Intern Med; 1998; 43():279-320. PubMed ID: 9506186
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of multiple myeloma by high dose chemotherapy, total body irradiation and autologous blood stem cell autograft.
    Fermand JP; Lévy Y; Gerota J; Benbunan M; Cosset JM; Castaigne S; Seligmann M; Brouet JC
    Nouv Rev Fr Hematol (1978); 1989; 31(2):85-7. PubMed ID: 2570400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma: the therapeutic options].
    Sánchez Fayos J; Prieto E; Roman A; Olavarria E
    An Med Interna; 1992 Feb; 9 Spec No():112-8. PubMed ID: 1550902
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged survival after intensive therapy and purged ABMT in patients with multiple myeloma.
    Reece DE; Brockington DA; Phillips GL; Barnett MJ; Klingemann HG; Nantel SH; Sutherland HJ; Shepherd JD
    Bone Marrow Transplant; 2000 Sep; 26(6):621-6. PubMed ID: 11041567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment.
    Powles R; Raje N; Milan S; Millar B; Shepherd V; Mehta J; Singhal S; Kulkarni S; Viner C; Gore M; Cunningham D; Treleaven J
    Bone Marrow Transplant; 1997 Sep; 20(6):435-43. PubMed ID: 9313875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is alpha-interferon treatment in multiple myeloma worthwhile?
    Avvisati G; Petrucci MT
    Stem Cells; 1995 Aug; 13 Suppl 2():106-13. PubMed ID: 8520497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance treatment with recombinant alpha interferon after autologous bone marrow transplantation for aggressive myeloma in first remission after conventional induction chemotherapy.
    Attal M; Huguet F; Schlaifer D; Payen C; Lassoued S; Laroche M; Rossi JF; Fournie B; Mazieres B; Pris J
    Bone Marrow Transplant; 1991 Aug; 8(2):125-8. PubMed ID: 1933053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in treatment of multiple myeloma].
    Gola A
    Acta Haematol Pol; 1992; 23(4):229-35. PubMed ID: 1293903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of multiple myeloma--present status and perspectives].
    Robak T
    Acta Haematol Pol; 1996; 27(1):5-14. PubMed ID: 8629444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.